Pediatric Parenteral Nutrition (PPN)

Parenteral nutrition (PN) is the intravenous provision of nutrients when enteral feeding is insufficient or impossible. In children, the therapeutic window is narrow, and careful planning is essential to support growth, organ development, and recovery from illness.

When Is Parenteral Nutrition Indicated?

• Severe gastrointestinal malabsorption (e.g., shortbowel syndrome, congenital intestinal atresia)
• Intestinal obstruction or postoperative ileus that prevents enteral intake for >57 days
• High metabolic demand with inadequate oral/enteral intake (e.g., severe burns, major trauma, sepsis)
• Congenital metabolic disorders requiring strict control of nutrient delivery
• Premature infants with feeding intolerance or who require additional caloric support

Goals of Pediatric PN

1. Provide adequate calories to meet basal metabolic rate plus growth demands.
2. Supply macronutrients (carbohydrate, protein, fat) in proportions appropriate for the childs age and clinical condition.
3. Maintain electrolyte, traceelement, and vitamin balance to prevent deficiencies or toxicities.
4. Promote anabolism and wound healing while minimizing catabolism.
5. Support immune function and reduce the risk of infection.

Components of a Pediatric PN Formula

Types of Catheters

Choosing the right vascular access is a balance between duration of therapy and risk of complications.

• Peripheral cannulas: Suitable for shortterm PN (<7days). Limited flow rates (1mL/kg/hr).
• Peripherally inserted central catheter (PICC): Preferred for mediumterm (weeks to months) PN. Allows higher osmolarity solutions.
• Implanted tunneled catheters (e.g., Broviac, Hickman): Used for longterm PN in children with chronic intestinal failure.
• Implantable ports: Provide a closed system; useful in ambulatory patients.

Monitoring and Safety

Frequent assessment prevents metabolic derangements and linerelated infections.

Laboratory Monitoring

Clinical Monitoring

• Weight and length/height measured at least weekly.
• Fluid balance: input vs. output, daily weights.
• Inspection of catheter site for erythema, discharge, or pain.
• Signs of metabolic complications: hyperglycemia, hypertriglyceridemia, cholestasis.

Common Complications

Metabolic

• Hyperglycemia: Adjust glucose infusion rate; consider insulin infusion.
• Hypoglycemia: Reduce insulin or increase glucose.
• Hypertriglyceridemia: Reduce lipid dose or give lipidfree days.
• Essential fattyacid deficiency: Prevent by providing at least 0.51% of total calories as linoleic acid.
• Refeeding syndrome: Start low and increase gradually; monitor phosphate, potassium, magnesium.

Infectious

Catheterrelated bloodstream infections (CRBSI) are the most serious risk.

• Use aseptic technique for line access.
• Prefer closed system (e.g., needleless connectors).
• Routine line changes only when clinically indicated.
• Consider antimicrobialimpregnated catheters in highrisk patients.

Hepatic

Prolonged PN may cause cholestasis or steatosis. Strategies to minimise liver injury include:

• Using fishoil based or mixedoil lipid emulsions (lower 6/3 ratio).
• Cycling the infusion (e.g., 12hour cycles) to allow hepatic rest.
• Providing minimal amounts of phytosterols.
• Introducing trophic enteral feeds as soon as tolerated.

Transition to Enteral Feeding

Enteral nutrition (EN) is the preferred route and should be introduced early.

1. Start with trophic feeds (1020mL/kg/day) if the gut is functional.
2. Gradually increase volume while monitoring tolerance (abdominal distention, vomiting, stools).
3. Reduce PN proportionally; avoid abrupt cessation to prevent catabolism.
4. Reevaluate electrolyte and micronutrient needs as EN contribution rises.

Special Populations

Premature Infants

Very lowbirthweight (VLBW) infants have higher protein needs (3.54.5g/kg/day) and require rapid provision of calories (120150kcal/kg/day) to achieve growth comparable to intrauterine rates.

Children with Intestinal Failure

Longterm PN may be needed. Management focuses on:

• Optimising lipid composition to protect liver.
• Monitoring for central lineassociated thrombosis.
• Planning for intestinal transplantation when appropriate.

Metabolic Disorders

Conditions such as phenylketonuria or ureacycle defects require custom aminoacid solutions that omit offending substrates.

Guidelines and Resources

Current bestpractice recommendations are published by:

• American Society for Parenteral and Enteral Nutrition (ASPEN)
• European Society for Clinical Nutrition and Metabolism (ESPEN)
• British Association of Paediatric Surgeons (BAPS) guidelines on intestinal failure

Clinicians are encouraged to use these resources in conjunction with local protocols and multidisciplinary teams that include neonatologists, pediatric surgeons, dietitians, pharmacists, and nursing staff.

Conclusion

Pediatric parenteral nutrition is a lifesaving intervention when enteral feeding is insufficient. Successful therapy requires individualized formulation, vigilant monitoring, and a clear plan for transitioning to enteral nutrition. By adhering to evidencebased guidelines and maintaining a multidisciplinary approach, clinicians can minimise complications and support optimal growth and development in children who depend on PN.